NASDAQ:GVH Globavend (GVH) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free GVH Stock Alerts $1.08 -0.02 (-1.82%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$1.08▼$1.2250-Day Range$0.90▼$1.7152-Week Range$0.79▼$5.50Volume54,363 shsAverage Volume155,414 shsMarket Capitalization$15.79 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Globavend alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Globavend Stock (NASDAQ:GVH)Globavend Holdings Limited, together with its subsidiaries, provides integrated cross-border logistics services and air freight forwarding services in Hong Kong, Australia, and New Zealand. The company's services include parcel consolidation, air freight forwarding, customs clearance, on-carriage parcel transportation, and delivery. It serves e-commerce merchants and operators of e-commerce platforms. The company was founded in 2016 and is based in Perth, Australia. Globavend Holdings Limited is subsidiary of Globavend Investments Limited.Read More GVH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GVH Stock News HeadlinesApril 18, 2024 | finance.yahoo.comGlobavend Holdings Limited (GVH)April 8, 2024 | msn.comWhy Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving PremarketApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 18, 2024 | msn.comGlobavend Holdings enters into $20 mln equity line of credit facilityMarch 18, 2024 | globenewswire.comGlobavend Holdings Limited Enters Into a US$20,000,000 Equity Line of Credit Facility to be Registered on Form F-1February 20, 2024 | money.usnews.comGlobavend Holdings Ltd.February 4, 2024 | morningstar.comGlobavend Holdings Ltd GVHFebruary 1, 2024 | msn.comFibroBiologics stock tumbles 20% during second day of tradingApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 1, 2024 | seekingalpha.comFibroBiologics goes public through direct listing on NasdaqJanuary 23, 2024 | markets.businessinsider.comWhy 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionDecember 20, 2023 | uk.investing.comGlobavend Holdings Ltd (GVH)December 18, 2023 | finance.yahoo.comGlobavend Holdings Limited Announces Pricing of Initial Public OfferingDecember 18, 2023 | finance.yahoo.comCan Globavend Holdings Limited (NASDAQ:GVH) Maintain Its Strong Returns?December 18, 2023 | finance.yahoo.comGlobavend Holdings Limited Announces Closing of its Initial Public OfferingSee More Headlines Receive GVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Globavend and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorRetail/Wholesale Industry Freight transportation arrangement Sub-IndustryN/A Current SymbolNASDAQ:GVH Previous SymbolNASDAQ:GVH CUSIPN/A CIK1978527 Webwww.globavend.com Phone61-8-6141-3263FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.03 Quick Ratio1.03 Sales & Book Value Annual Sales$18.59 million Price / Sales0.85 Cash Flow$0.07 per share Price / Cash Flow14.94 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares14,620,000Free FloatN/AMarket Cap$15.79 million OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Wai Yiu Yau (Age 40)Founder, Chairman of the Board & CEO Comp: $85kMr. Tsz Ngo Yu (Age 38)Chief Financial Officer Key CompetitorsXcel BrandsNASDAQ:XELBWebuy GlobalNASDAQ:WBUYAkso Health GroupNASDAQ:AHGYunjiNASDAQ:YJMOGUNYSE:MOGUView All Competitors GVH Stock Analysis - Frequently Asked Questions How have GVH shares performed in 2024? Globavend's stock was trading at $1.5752 at the start of the year. Since then, GVH stock has decreased by 31.4% and is now trading at $1.08. View the best growth stocks for 2024 here. Are investors shorting Globavend? Globavend saw a increase in short interest in April. As of April 15th, there was short interest totaling 82,600 shares, an increase of 15.0% from the March 31st total of 71,800 shares. Based on an average trading volume of 75,600 shares, the days-to-cover ratio is presently 1.1 days. View Globavend's Short Interest. When did Globavend IPO? Globavend (GVH) raised $6 million in an IPO on Wednesday, November 8th 2023. The company issued 1,500,000 shares at a price of $4.00 per share. R.F. Lafferty & Co. served as the underwriter for the IPO. When does the company's lock-up period expire? Globavend's lock-up period expires on Monday, May 6th. Globavend had issued 1,500,000 shares in its public offering on November 8th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. After the end of the company's lock-up period, company insiders and major shareholders will be able to sell their shares of the company. How do I buy shares of Globavend? Shares of GVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GVH) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globavend Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
